A randomized, double blind, comparative study of STATUS D3 (vitamin D3) versus placebo in patients with lung cancer to prevent relapse after operation

A randomized, double blind, comparative study of STATUS D3 (vitamin D3) versus placebo in patients with lung cancer to prevent relapse after operation - Amaterasu 4

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001869

Enrollment

300

Registered

2009-04-10

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

vitamin D3 suppliment placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. First operation for lung cancer at Jikei University hospitals 2. Obtained informed consent 3. Age 20 and more and less than 75 years old

Exclusion criteria

Exclusion criteria: 1. Already taking vitamin D supplement or 1,25 vitamin D 2. History of kidney stone 3. Other difficulties judged by the surgeon in charge

Design outcomes

Primary

Measure	Time frame
disease free survival	—

Countries

Japan

Contacts

Public ContactEmi Suzuki

Jikei University School of Medicine Division of Molecular Epidemiology

emisuzu@jikei.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026